FiercePharma  Nov 25  Comment 
Earlier this month, Perrigo shareholders spurned a hostile buyout attempt from Mylan. And now, the Netherlands-based company may have to go up against its former target if it wants to pursue a replacement buy.
FiercePharma  Nov 23  Comment 
After finally turning back the long-running takeover attempt by Mylan, Perrigo assured shareholders they could expect "industry-leading future growth prospects." In its first move toward delivering on that promise, the OTC specialist said today...
GenEng News  Nov 23  Comment 
Perrigo said today it will acquire Entocort® (budesonide) capsules and the authorized generic capsules marketed by Par Pharmaceuticals within the U.S. from AstraZeneca for $380 million. Perrigo said Entocort®, a gastroenterology medicine for...
newratings.com  Nov 23  Comment 
LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) announced it has entered into an agreement with Perrigo Company plc for the divestment of US rights to Entocort (budesonide), a gastroenterology medicine for patients with mild to moderate Crohn's...
Forbes  Nov 20  Comment 
Looking at the universe of stocks we cover at Dividend Channel, on 11/24/15, Weis Markets, Inc. (NYSE: WMK), NextEra Energy Inc (NYSE: NEE), and Perrigo Company plc (NYSE: PRGO) will all trade ex-dividend for their respective upcoming dividends....
Forbes  Nov 17  Comment 
The best performing sector as of midday Tuesday is the Healthcare sector, higher by 1.0%. Within the sector, HCA Holdings Inc (NYSE: HCA) and Perrigo Company plc (NYSE: PRGO) are two large stocks leading the way, showing a gain of 3.4% and 3.2%,...
Benzinga  Nov 16  Comment 
Analysts at Citigroup upgraded CA, Inc. (NASDAQ: CA) from Sell to Neutral. CA shares closed at $26.53 on Friday. Barclays upgraded AIXTRON SE (ADR) (NASDAQ: AIXG) from Equal-weight to Overweight. The price target for Aixtron has been raised...
Wall Street Journal  Nov 13  Comment 
Mylan’s failed hostile takeover deal for Perrigo leaves both pharmaceutical companies nursing wounds.
New York Times  Nov 13  Comment 
The pharmaceutical company said it had collected some 40 percent of the shares of its rival in a tender offer.
newratings.com  Nov 13  Comment 


Perrigo Company is a global health-care supplier and the world's largest manufacturer of over-the-counter pharmaceuticals for the store brand market. The company develops, distributes, and manufactures over-the-counter and prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients, and consumer products.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki